Basilea Pharmaceutica AG (0QNA.L) LSE

51.90

+0.2(+0.39%)

Updated at August 18 04:59PM

Currency In CHF

Valuation

Market Cap499.91M
Enterprise Value490.88M
P/E Ratio9.22
PEG Ratio0
Price/Sales Ratio3.11
Price/Book Ratio8.83
Enterprise/Revenue3.07
Enterprise/EBITDA10.14

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterDecember 31, 2024

Profitability

Profit Margin0.37
Operating Margin0.29

Management Effectiveness

Return On Assets0.3
Return On Equity1.59

Income Statement

Revenue208.54M
Revenue/Share15.42
Gross Profit169.86M
EBITDA63.13M
Net Income77.59M
Diluted EPS5.6

Balance Sheet

Total Cash120.71M
Total Cash/Share8.93
Total Debt111.67M
Total Debt/Equity1.38
Current Ratio4.85
Book Value Per Share5.99

Price History

52-Week Change17.02
52-Week High52.35
52-Week Low32.2
Moving Average 50 Days35.23
Moving Average 200 Days39.55

Statistics

Average Volume4,885
Shares Outstanding12.28M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A